<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04366102</url>
  </required_header>
  <id_info>
    <org_study_id>U1111-1242-9663</org_study_id>
    <nct_id>NCT04366102</nct_id>
  </id_info>
  <brief_title>Reducing Pain and Promoting Neurodevelopment Among Preterm Neonates</brief_title>
  <official_title>Multisensory Stimulation and Soft Tissue Therapy in Managing Procedural Pain Among Preterm Neonates: A Parallel-Group, Pretest-posttest Randomized Clinical Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Asir John Samuel</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Maharishi Markendeswar University (Deemed to be University)</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Maharishi Markendeswar University (Deemed to be University)</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      To determine the effects of multisensory stimulation and soft tissue therapy on procedural&#xD;
      pain and neurodevelopment among neonates admitted to the NICU is the aim of the study. The&#xD;
      study will be two groups randomized clinical trial of five days intervention program. The&#xD;
      intervention will be given among two groups. Group A will receive both multisensory&#xD;
      stimulation and soft tissue therapy, Group B will receive only regular hospital care. The&#xD;
      PIPP and N-PASS will be used for assessing pain. The INFANIB and Premie-Neuro will be used&#xD;
      for assessing neuromotor development among neonates. The outcomes will be taken before and&#xD;
      after the fifth day of the intervention. Multisensory stimulation and soft tissue therapy&#xD;
      might help in reducing pain and promoting neurodevelopment.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This study will utilize two parallel groups, randomised design to analyze the effects of soft&#xD;
      tissue therapy and multisensory stimulation on pain and neurodevelopment. 104 neonates&#xD;
      admitted in NICU will be recruited through purposive sampling for the trial. Procedural pain&#xD;
      will be assessed with PIPP and N-PASS through recorded video. Neurodevelopmental outcomes&#xD;
      will be assessed with INFANIB Scale and Premie-Neuro. The measurements will be taken after 24&#xD;
      hours of birth at the baseline and after the fifth day of the intervention. The treatment&#xD;
      will be given into two groups i.e. Group A (Multisensory stimulation and soft tissue therapy&#xD;
      group), Group B (routine hospital care). MSS will consist of Auditory Stimulation,&#xD;
      Tacto-Kinesthetic stimulation, Vestibular stimulation, Visual stimulation, Oral-stimulation,&#xD;
      and Olfactive stimulation. Soft tissue therapy consisted of stroking, effleurage, skin&#xD;
      rolling, and kneading techniques, Will be given in 5 Phases-Forehead and face, Back and Neck,&#xD;
      Chest and abdomen, upper-lower limbs. Total 30 min. of the treatment plan, per day, will be&#xD;
      given to the neonates, after 30 min. of feed, for up to 5 days of NICU stay.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 12, 2021</start_date>
  <completion_date type="Anticipated">August 18, 2023</completion_date>
  <primary_completion_date type="Anticipated">June 28, 2023</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Neonates admitted in the Neonatal intensive care unit will be divided randomly into 2 groups.</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>The Premature infant pain profile (PIPP)</measure>
    <time_frame>Change score of PIPP at the baseline(immediately after painful procedure, at 30s, 60s, 90s, and 120s) and after five days of intervention</time_frame>
    <description>Measuring procedural pain among neonates, having 1 to 3 scoring. 0 describe normal and 3 describes low score</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Neonatal pain agitation sedation scale (N-PASS)</measure>
    <time_frame>Change score of N-PASS at the baseline(immediately after painful procedure, at 30s, 60s, 90s, and 120s) and after five days of intervention</time_frame>
    <description>Measuring procedural pain along with sedation, having score ranged from 0 to 2, 0 describes normal and 2 describes low score</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Infant neurological international battery (INFANIB)</measure>
    <time_frame>Change score of INFANIB at the baseline and after five days of intervention</time_frame>
    <description>Measuring neurodevelopmental outcomes among preterm neonates. Scoring is from 5, 3, and 1. Score 5 means Normal, score 3 means mildly abnormal, score 1 means markedly abnormal. Total score for preterm neonate is 70.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Premie-Neuro</measure>
    <time_frame>Change score of Premie-Neuro at the baseline and after five days of intervention</time_frame>
    <description>Premie-neuro used for measuring neurodevelopmental outcome in preterm neonates between 23 and 37 weeks of gestation. It has total 24 items. Each item has a score of 1,3, and 5. Total score is 120. Score less than 70 is considered as abnormal, score between 70-99 is questionable, and score above 100 is normal.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">104</enrollment>
  <condition>Neonatal Disease</condition>
  <condition>Neonatal Disorder</condition>
  <arm_group>
    <arm_group_label>Group A</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Multisensory stimulation and soft tissue therapy</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Routine Hospital care</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Multisensory stimulation with soft tissue therapy</intervention_name>
    <description>Multisensory stimulation with soft tissue therapy will be given. Multisensory stimulation consists of Auditory, vestibular, tactile, olfactive, oromotor, Visual, and Kinesthetic stimulation. Soft tissue therapy consists of stroking, effleurage, fingertip kneading, tapping, and skin rolling will be given. Total intervention will be given for 30 min. 5 times per week</description>
    <arm_group_label>Group A</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Routine hospital care</intervention_name>
    <description>Routine hospital care will be given to the preterm neonates</description>
    <arm_group_label>Group B</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria&#xD;
&#xD;
          -  Preterm between 30- 36 weeks of gestation&#xD;
&#xD;
          -  Birth weight &gt;1500 g&#xD;
&#xD;
          -  Not receiving analgesics/sedatives&#xD;
&#xD;
          -  APGAR score ranged between 4-6 in 1 min. &amp; 7 to 9 in 5 min.&#xD;
&#xD;
          -  Undergoing routine healthcare procedures in NICU&#xD;
&#xD;
        Exclusion Criteria&#xD;
&#xD;
          -  Preterm with surgery&#xD;
&#xD;
          -  Preterm having unstable vitals&#xD;
&#xD;
          -  Preterm with congenital malformations&#xD;
&#xD;
          -  Preterm who require mechanical ventilation&#xD;
&#xD;
          -  Having inborn errors of metabolism and also with seizures disorders,&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>5 Days</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Neha Sharma, MPT</last_name>
    <role>Principal Investigator</role>
    <affiliation>Maharishi Markandeshwar institute of Physiotherapy and Rehabilitation</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Asir J Samuel, MPT, PhD</last_name>
    <role>Study Chair</role>
    <affiliation>Maharishi Markandeshwar Institute of physiotherapy and Rehabilitation</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Asir J Samuel, MPT, PhD</last_name>
    <phone>8059930222</phone>
    <email>asirjohnsamuel@mmumullana.org</email>
  </overall_contact>
  <link>
    <url>http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6045934/</url>
    <description>Effect of Multi-sensory Stimulation on Neuromuscular Development of Premature Infants: A Randomized Clinical Trial</description>
  </link>
  <link>
    <url>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4311795/</url>
    <description>Pain assessment scales in newborns: integrative review</description>
  </link>
  <reference>
    <citation>Zeraati H, Nasimi F, Rezaeian A, Shahinfar J, Ghorban Zade M. Effect of Multi-sensory Stimulation on Neuromuscular Development of Premature Infants: A Randomized Clinical Trial. Iran J Child Neurol. 2018 Summer;12(3):32-39.</citation>
    <PMID>30026767</PMID>
  </reference>
  <reference>
    <citation>de Melo GM, LÃ©lis AL, de Moura AF, Cardoso MV, da Silva VM. [Pain assessment scales in newborns: integrative review]. Rev Paul Pediatr. 2014 Dec;32(4):395-402. doi: 10.1016/j.rpped.2014.04.007. Review. Portuguese.</citation>
    <PMID>25511005</PMID>
  </reference>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>April 25, 2020</study_first_submitted>
  <study_first_submitted_qc>April 25, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">April 28, 2020</study_first_posted>
  <last_update_submitted>October 9, 2021</last_update_submitted>
  <last_update_submitted_qc>October 9, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">October 18, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>Maharishi Markendeswar University (Deemed to be University)</investigator_affiliation>
    <investigator_full_name>Asir John Samuel</investigator_full_name>
    <investigator_title>Associate professor</investigator_title>
  </responsible_party>
  <keyword>Neonates</keyword>
  <keyword>Pain</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infant, Newborn, Diseases</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Individual participant data (IPD) will be shared via Mendeley Dataset</ipd_description>
    <ipd_info_type>Study Protocol</ipd_info_type>
    <ipd_info_type>Statistical Analysis Plan (SAP)</ipd_info_type>
    <ipd_info_type>Informed Consent Form (ICF)</ipd_info_type>
    <ipd_time_frame>Study Protocol - December, 2020 Statistical Analysis Plan (SAP) - December, 2020 Informed Consent Form (ICF) - December, 2020</ipd_time_frame>
    <ipd_access_criteria>By publishing study protocol with detailed statistical Analysis Plan in SCOPUS and PubMed indexed journals</ipd_access_criteria>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

